LimFlow Archives - M&L Group

Healthcare

LimFlow Announces Agreement to Be Acquired by Inari Medical

1 November 2023 – PARIS & SAN JOSE, California LimFlow SA, a pioneer in the development…

Natalie GoodridgeNovember 1, 2023

Healthcare

CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris

9 October 2023 – CLICHY, France CorWave, a French company that develops and manufactures innovative cardiac…

Natalie GoodridgeOctober 9, 2023

Healthcare

M&L Healthcare’s First MedTech Investment Receives FDA Approval Following Successful US Trials

15 September 2023 – Singapore M&L Healthcare, in its first major MedTech investment, has announced the…

Natalie GoodridgeSeptember 15, 2023

Healthcare

FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options

12 September 2023 – PARIS & SAN JOSE, California LimFlow SA, a pioneer in the development…

Natalie GoodridgeSeptember 12, 2023

Healthcare

LimFlow Raises $40 Million (€36 Million) in Series D Financing

5 April 2022 – PARIS, France LimFlow SA, a pioneer in the development of minimally-invasive technology…

Natalie GoodridgeApril 5, 2022

Healthcare

Late-breaking Data From PROMISE I Study On LimFlow System Confirm Excellent Sustained Outcomes In Patients With No-option Chronic Limb-threatening Ischemia

7 October 2021 – SAN JOSE, Calif. and LAS VEGAS LimFlow SA, the pioneer in the…

Natalie GoodridgeOctober 7, 2021

Healthcare

Publication of 1-year Outcomes from PROMISE I of LIMFLOW System Demonstrates Excellent Sustained AFS and Wound Healing in No-option CLTI Patients

20 May 2021 – PARIS, France LimFlow SA, the pioneer in the development of minimally-invasive technology…

Natalie GoodridgeMay 20, 2021

Healthcare

LimFlow Receives Japan PMDA Approval for Clinical Study of Minimally Invasive Technology Designed to Prevent Amputations in CLTI Patients

23 March 2021 – PARIS, France LimFlow SA, a pioneer in the development of minimally-invasive technology…

Natalie GoodridgeMarch 23, 2021

Healthcare

LimFlow System Demonstrates Excellent Sustained Amputation-Free Survival and Wound Healing at One Year in PROMISE I U.S. Study

6 November 2020 – PARIS, France LimFlow SA, the pioneer in the development of minimally-invasive technology…

Natalie GoodridgeNovember 6, 2020

Healthcare

Sofinnova Partners Announces Two First Investments from its MD Start III Medtech Acceleration Fund

2 July 2020 – PARIS, France Sofinnova Partners, a leading European life sciences venture capital firm…

Natalie GoodridgeJuly 2, 2020

LimFlow

LimFlow Announces Agreement to Be Acquired by Inari Medical

CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris

M&L Healthcare’s First MedTech Investment Receives FDA Approval Following Successful US Trials

FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options

LimFlow Raises $40 Million (€36 Million) in Series D Financing

Late-breaking Data From PROMISE I Study On LimFlow System Confirm Excellent Sustained Outcomes In Patients With No-option Chronic Limb-threatening Ischemia

Publication of 1-year Outcomes from PROMISE I of LIMFLOW System Demonstrates Excellent Sustained AFS and Wound Healing in No-option CLTI Patients

LimFlow Receives Japan PMDA Approval for Clinical Study of Minimally Invasive Technology Designed to Prevent Amputations in CLTI Patients

LimFlow System Demonstrates Excellent Sustained Amputation-Free Survival and Wound Healing at One Year in PROMISE I U.S. Study

Sofinnova Partners Announces Two First Investments from its MD Start III Medtech Acceleration Fund

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact